Edap Tms (NASDAQ:EDAP) Given New $4.50 Price Target at Piper Sandler

Edap Tms (NASDAQ:EDAP) had its price target lowered by equities research analysts at Piper Sandler from $5.00 to $4.50 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. Piper Sandler’s price target would suggest a potential upside of 109.30% from the stock’s previous close.

A number of other equities analysts have also recently issued reports on EDAP. HC Wainwright reiterated a “buy” rating and issued a $19.00 price objective on shares of Edap Tms in a report on Friday. StockNews.com assumed coverage on Edap Tms in a research note on Friday. They issued a “hold” rating for the company.

Edap Tms Price Performance

EDAP stock opened at $2.15 on Friday. The firm has a 50 day simple moving average of $2.42 and a two-hundred day simple moving average of $2.50. The stock has a market cap of $79.77 million, a PE ratio of -3.31 and a beta of 0.37. Edap Tms has a one year low of $1.96 and a one year high of $8.50. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. The company had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, analysts predict that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Trading of Edap Tms

Several hedge funds have recently added to or reduced their stakes in EDAP. Illumine Investment Management LLC bought a new stake in shares of Edap Tms in the 4th quarter valued at about $50,000. BNP Paribas Financial Markets lifted its position in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 4,400 shares during the last quarter. Jane Street Group LLC boosted its stake in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares during the period. Millennium Management LLC grew its holdings in shares of Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after purchasing an additional 33,558 shares during the last quarter. Finally, Orion Capital Management LLC increased its stake in shares of Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after buying an additional 6,600 shares during the period. 62.74% of the stock is owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.